Evercyte highlights immortalized cell technology at SelectBIO Rotterdam 2024
June 27th, 2024, Vienna, Austria
We participated as technology spotlight speakers at the SelectBio Europe 2024 meeting in Rotterdam, the Netherlands.
Dr. Regina Grillari, our co-founder and COO/CSO, delivered a talk titled ‘Human Telomerized Cell Cultures to Establish Relevant and Standardizable Pre-Clinical in vitro Test Systems‘ highlighting the significance of our immortalized cell lines for different applications, such as producing scalable clinical-grade extracellular vesicles (EVs), establishing complex in vitro models, simulating single or multi-organ systems, and constructing living tissue models with bioprinting.
Explore our portfolio featuring immortalized cell lines and our specialized services in cell line development.